TTNP

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Titan Pharmaceuticals (TTNP – Research Report) and Crinetics Pharmaceuticals (CRNX – Research Report). Titan Pharmaceuticals (TTNP) In a report released today, Jason McCarthy from Maxim Group downgraded Titan Pharmaceuticals to Hold. The company's shares closed last Wednesday at $0.38, close to its 52-week low of $0.35. According to TipRanks.com, McCarthy has 0 stars on 0-5 stars ranking scale with an average return of -16.9% and a 24.0% success rate. Schwartz covers the Healthcare sector, focusing on stocks such as Applied Molecular Transport, Mereo Biopharma Group Plc, and Ultragenyx Pharmaceutical.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-titan-pharmaceuticals-ttnp-and-crinetics-pharmaceuticals-crnx?utm_source=advfn.com&utm_medium=referral